These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 6369119)

  • 21. Quantitative analyses of the relationship between C3 consumption, C3b capture, and immune adherence of complement-fixing antibody/DNA immune complexes.
    Edberg JC; Tosic L; Wright EL; Sutherland WM; Taylor RP
    J Immunol; 1988 Dec; 141(12):4258-65. PubMed ID: 3198918
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Beyond Binding: The Outcomes of Antibody-Dependent Complement Activation in Human Malaria.
    Rathnayake D; Aitken EH; Rogerson SJ
    Front Immunol; 2021; 12():683404. PubMed ID: 34168652
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Complement activation in experimental human malaria infection.
    Roestenberg M; McCall M; Mollnes TE; van Deuren M; Sprong T; Klasen I; Hermsen CC; Sauerwein RW; van der Ven A
    Trans R Soc Trop Med Hyg; 2007 Jul; 101(7):643-9. PubMed ID: 17481680
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human monoclonal IgG isotypes differ in complement activating function at the level of C4 as well as C1q.
    Bindon CI; Hale G; Brüggemann M; Waldmann H
    J Exp Med; 1988 Jul; 168(1):127-42. PubMed ID: 3260935
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Studies on the in vivo effects of antibody. Interaction of IgM antibody and complement in the immune clearance and destruction of erythrocytes in man.
    Atkinson JP; Frank MM
    J Clin Invest; 1974 Aug; 54(2):339-48. PubMed ID: 4847248
    [TBL] [Abstract][Full Text] [Related]  

  • 26. How naturally occurring anti-band 3 antibodies stimulate C3b deposition to senescent and oxidatively stressed red blood cells.
    Lutz HU; Stammler P; Fasler S
    Biomed Biochim Acta; 1990; 49(2-3):S224-9. PubMed ID: 2386510
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasmodium falciparum: the Pf332 antigen is secreted from the parasite by a brefeldin A-dependent pathway and is translocated to the erythrocyte membrane via the Maurer's clefts.
    Hinterberg K; Scherf A; Gysin J; Toyoshima T; Aikawa M; Mazie JC; da Silva LP; Mattei D
    Exp Parasitol; 1994 Nov; 79(3):279-91. PubMed ID: 7957750
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Autosomal locus regulates inverse relationship between sialic acid content and capacity of mouse erythrocytes to activate human alternative complement pathway.
    Nydegger UE; Fearon DT; Austen KF
    Proc Natl Acad Sci U S A; 1978 Dec; 75(12):6078-82. PubMed ID: 282625
    [TBL] [Abstract][Full Text] [Related]  

  • 29. C5 convertase of the alternative complement pathway: covalent linkage between two C3b molecules within the trimolecular complex enzyme.
    Kinoshita T; Takata Y; Kozono H; Takeda J; Hong KS; Inoue K
    J Immunol; 1988 Dec; 141(11):3895-901. PubMed ID: 3183384
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of antibody isotype and antigenic epitope density on the complement-fixing activity of immune complexes: a systematic study using chimaeric anti-NIP antibodies with human Fc regions.
    Lucisano Valim YM; Lachmann PJ
    Clin Exp Immunol; 1991 Apr; 84(1):1-8. PubMed ID: 1707767
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of complement activation on the surface of cells after incorporation of decay-accelerating factor (DAF) into their membranes.
    Medof ME; Kinoshita T; Nussenzweig V
    J Exp Med; 1984 Nov; 160(5):1558-78. PubMed ID: 6238120
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of the interactions between properdin, the third component of complement (C3), and its physiological activation products.
    Farries TC; Lachmann PJ; Harrison RA
    Biochem J; 1988 May; 252(1):47-54. PubMed ID: 3421908
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Selective lysis of erythrocytes infected with the trophozoite stage of Plasmodium falciparum by polyene macrolide antibiotics.
    Wiehart UI; Rautenbach M; Hoppe HC
    Biochem Pharmacol; 2006 Mar; 71(6):779-90. PubMed ID: 16436272
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phagocytosis by human monocytes of particles activating the alternative pathway of complement.
    Johnson E; Eskeland T; Bertheussen K
    Scand J Immunol; 1984 Jan; 19(1):31-9. PubMed ID: 6701471
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of monoclonal anti-C3 antibodies to characterise the fragments of C3 that are found on erythrocytes.
    Lachmann PJ; Voak D; Oldroyd RG; Downie DM; Bevan PC
    Vox Sang; 1983; 45(5):367-72. PubMed ID: 6605620
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CD14(hi)CD16+ monocytes phagocytose antibody-opsonised Plasmodium falciparum infected erythrocytes more efficiently than other monocyte subsets, and require CD16 and complement to do so.
    Zhou J; Feng G; Beeson J; Hogarth PM; Rogerson SJ; Yan Y; Jaworowski A
    BMC Med; 2015 Jul; 13():154. PubMed ID: 26149666
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antibodies in malarial sera to parasite antigens in the membrane of erythrocytes infected with early asexual stages of Plasmodium falciparum.
    Perlmann H; Berzins K; Wahlgren M; Carlsson J; Björkman A; Patarroyo ME; Perlmann P
    J Exp Med; 1984 Jun; 159(6):1686-704. PubMed ID: 6374012
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The mechanism of activation of the alternative pathway of complement by cell-bound C4b.
    Farries TC; Steuer KL; Atkinson JP
    Mol Immunol; 1990 Nov; 27(11):1155-61. PubMed ID: 2247091
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HIV-1 and HIV-2 isolates differ in their ability to activate the complement system on the surface of infected cells.
    Marschang P; Gürtler L; Tötsch M; Thielens NM; Arlaud GJ; Hittmair A; Katinger H; Dierich MP
    AIDS; 1993 Jul; 7(7):903-10. PubMed ID: 7689323
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Classical complement pathway activation on nucleated cells. Role of factor H in the control of deposited C3b.
    Ollert MW; David K; Bredehorst R; Vogel CW
    J Immunol; 1995 Nov; 155(10):4955-62. PubMed ID: 7594501
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.